MAZE vs MNST · rev $20.0M vs P/E 46, rev $4.89B
Maze Therapeutics, Inc. Common Stock (MAZE) versus Monster Beverage Corp (MNST) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Monster Beverage Corp (MNST) is a beverages - non-alcoholic company listed on US.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
Latest reported MNST revenue for 2026-06-30 was $4.89B. Net income was $1.15B. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
MAZE currently screens at market cap $525.3M. MNST currently screens at market cap $94.01B and trailing P/E 46.4.
Not investment advice. Open the MAZE and MNST stock pages for the full models.
Not investment advice.